| The Nitrogen‐Containing Bisphosphonate, Zoledronic Acid, Influences RANKL Expression in Human Osteoblast‐Like Cells by Activating TNF‐α Converting Enzyme (TACE) B Pan, AN Farrugia, LB To, DM Findlay, J Green, K Lynch, ... Journal of Bone and Mineral Research 19 (1), 147-154, 2004 | 417 | 2004 |
| Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway AR Wijenayaka, M Kogawa, HP Lim, LF Bonewald, DM Findlay, GJ Atkins PloS one 6 (10), e25900, 2011 | 391 | 2011 |
| Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors. N Udagawa, N Takahashi, T Katagiri, T Tamura, S Wada, DM Findlay, ... Journal of Experimental Medicine 182 (5), 1461-1468, 1995 | 385 | 1995 |
| Vascular pathology and osteoarthritis DM Findlay Rheumatology 46 (12), 1763-1768, 2007 | 305 | 2007 |
| Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1α, 25-dihydroxyvitamin D3 GJ Atkins, PH Anderson, DM Findlay, KJ Welldon, C Vincent, ... Bone 40 (6), 1517-1528, 2007 | 270 | 2007 |
| Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint DR Haynes, TN Crotti, M Loric, GI Bain, GJ Atkins, DM Findlay Rheumatology 40 (6), 623-630, 2001 | 261 | 2001 |
| Biocompatible polymer coating of titania nanotube arrays for improved drug elution and osteoblast adhesion K Gulati, S Ramakrishnan, MS Aw, GJ Atkins, DM Findlay, D Losic Acta biomaterialia 8 (1), 449-456, 2012 | 259 | 2012 |
| RANKL expression is related to the differentiation state of human osteoblasts GJ Atkins, P Kostakis, B Pan, A Farrugia, S Gronthos, A Evdokiou, ... Journal of Bone and Mineral Research 18 (6), 1088-1098, 2003 | 253 | 2003 |
| Receptor activator of nuclear factor-κB ligand expression by human myeloma cells mediates osteoclast formation in vitro and correlates with bone destruction in vivo AN Farrugia, GJ Atkins, LB To, B Pan, N Horvath, P Kostakis, DM Findlay, ... Cancer research 63 (17), 5438-5445, 2003 | 250 | 2003 |
| Zoledronic acid protects against osteosarcoma‐induced bone destruction but lacks efficacy against pulmonary metastases in a syngeneic rat model A Labrinidis, S Hay, V Liapis, DM Findlay, A Evdokiou International journal of cancer 127 (2), 345-354, 2010 | 240 | 2010 |
| Calcitonin. PM Sexton, DM Findlay, TJ Martin Current medicinal chemistry 6 (11), 1067-1093, 1999 | 233 | 1999 |
| The proliferation and phenotypic expression of human osteoblasts on tantalum metal DM Findlay, K Welldon, GJ Atkins, DW Howie, ACW Zannettino, D Bobyn Biomaterials 25 (12), 2215-2227, 2004 | 226 | 2004 |
| Sclerostin is a locally acting regulator of late‐osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE‐ASARM‐dependent mechanism GJ Atkins, PS Rowe, HP Lim, KJ Welldon, R Ormsby, AR Wijenayaka, ... Journal of Bone and Mineral Research 26 (7), 1425-1436, 2011 | 224 | 2011 |
| The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis DR Haynes, TN Crotti, AE Potter, M Loric, GJ Atkins, DW Howie, ... The Journal of bone and joint surgery. British volume 83 (6), 902-911, 2001 | 223 | 2001 |
| Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response GJ Atkins, KJ Welldon, P Halbout, DM Findlay Osteoporosis International 20 (4), 653-664, 2009 | 217 | 2009 |
| Expression of osteoclast differentiation signals by stromal elements of giant cell tumors GJ Atkins, DR Haynes, SE Graves, A Evdokiou, S Hay, S Bouralexis, ... Journal of Bone and Mineral Research 15 (4), 640-649, 2000 | 210 | 2000 |
| Receptor activator NF-κB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients … TN Crotti, MD Smith, H Weedon, MJ Ahern, DM Findlay, M Kraan, PP Tak, ... Annals of the rheumatic diseases 61 (12), 1047-1054, 2002 | 206 | 2002 |
| Characterization of an osteoblast-like clonal cell line which responds to both parathyroid hormone and calcitonin SM Forrest, KW Ng, DM Findlay, VP Michelangeli, SA Livesey, ... Calcified Tissue International 37 (1), 51-56, 1985 | 202 | 1985 |
| Osteoprotegerin (OPG) is localized to the Weibel‐Palade bodies of human vascular endothelial cells and is physically associated with von Willebrand factor ACW Zannettino, CA Holding, P Diamond, GJ Atkins, P Kostakis, ... Journal of cellular physiology 204 (2), 714-723, 2005 | 197 | 2005 |
| Factors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss: Expression of receptor activator NFκB, RANK ligand and osteoprotegerin TN Crotti, MD Smith, DM Findlay, H Zreiqat, MJ Ahern, H Weedon, ... Biomaterials 25 (4), 565-573, 2004 | 194 | 2004 |
